GRAL GRAIL, Inc.
$126.89
GRAIL, Inc. (GRAL) is expected to report earnings on November 12, 2026, after the market close. The consensus earnings estimate is a loss of $2.84 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +86.6% since its last earnings release on August 5, 2026.
GRAIL Beat Consensus Estimates
Wednesday, August 5, 2026 · 4:02 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 12
Thursday · 4:00 PM ET
Earnings Whisper
-
vs ($2.84)
Rev est $43.5M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$82.11
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About GRAIL, Inc.
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured.
Sector
Healthcare
Industry
Medical Labs & Research
Charts powered in part by Lightweight Charts™ by TradingView.